115 related articles for article (PubMed ID: 38844470)
1. HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis.
Li X; Ma TK; Wang P; Shi H; Hai S; Qin Y; Zou Y; Zhu WT; Li HM; Li YN; Yin L; Xu YY; Yang Q; Zhang S; Ding H
Cell Death Dis; 2024 Jun; 15(6):398. PubMed ID: 38844470
[TBL] [Abstract][Full Text] [Related]
2. Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-β-mediated Nox4 expression.
Zhou B; Mu J; Gong Y; Lu C; Zhao Y; He T; Qin Z
Redox Biol; 2017 Apr; 11():390-402. PubMed ID: 28063381
[TBL] [Abstract][Full Text] [Related]
3. Intermedin inhibits unilateral ureteral obstruction-induced oxidative stress via NADPH oxidase Nox4 and cAMP-dependent mechanisms.
Qiao X; Wang L; Wang Y; Su X; Qi Y; Fan Y; Peng Z
Ren Fail; 2017 Nov; 39(1):652-659. PubMed ID: 28805491
[TBL] [Abstract][Full Text] [Related]
4. Kaempferitrin attenuates unilateral ureteral obstruction-induced renal inflammation and fibrosis in mice by inhibiting NOX4-mediated tubular ferroptosis.
Li J; Yang J; Xian Q; Su H; Ni Y; Wang L
Phytother Res; 2024 Jun; 38(6):2656-2668. PubMed ID: 38487990
[TBL] [Abstract][Full Text] [Related]
5. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis.
Wang B; Yang LN; Yang LT; Liang Y; Guo F; Fu P; Ma L
Acta Pharmacol Sin; 2024 Jan; 45(1):150-165. PubMed ID: 37696989
[TBL] [Abstract][Full Text] [Related]
6. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.
Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B
Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189
[TBL] [Abstract][Full Text] [Related]
7. Vitexin attenuates chronic kidney disease by inhibiting renal tubular epithelial cell ferroptosis via NRF2 activation.
Song J; Wang H; Sheng J; Zhang W; Lei J; Gan W; Cai F; Yang Y
Mol Med; 2023 Oct; 29(1):147. PubMed ID: 37891461
[TBL] [Abstract][Full Text] [Related]
8. CUX1 promotes epithelial-mesenchymal transition (EMT) in renal fibrosis of UUO model by targeting MMP7.
Teng S; Liu G; Li L; Ou J; Yu Y
Biochem Biophys Res Commun; 2022 Jun; 608():128-134. PubMed ID: 35397425
[TBL] [Abstract][Full Text] [Related]
9. EGR1/NOX4 pathway regulates oxidative stress and further facilitates fibrosis progression in keloids responses to TGF-β1.
Qin H; Zhang L; Li M; Liu Y; Sun S; Nie W; Bai B; Li G; Zhang G
J Dermatol Sci; 2022 Dec; 108(3):138-145. PubMed ID: 36608994
[TBL] [Abstract][Full Text] [Related]
10. Tubular NOX4 expression decreases in chronic kidney disease but does not modify fibrosis evolution.
Rajaram RD; Dissard R; Faivre A; Ino F; Delitsikou V; Jaquet V; Cagarelli T; Lindenmeyer M; Jansen-Duerr P; Cohen C; Moll S; de Seigneux S
Redox Biol; 2019 Sep; 26():101234. PubMed ID: 31247506
[TBL] [Abstract][Full Text] [Related]
11. Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis.
Jia J; Tan R; Xu L; Wang H; Li J; Su H; Zhong X; Liu P; Wang L
Int Immunopharmacol; 2024 Jun; 135():112303. PubMed ID: 38776855
[TBL] [Abstract][Full Text] [Related]
12. C/EBPα aggravates renal fibrosis in CKD through the NOX4-ROS-apoptosis pathway in tubular epithelial cells.
Xia Z; Wei Z; Li X; Liu Y; Gu X; Huang S; Zhang X; Wang W
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167039. PubMed ID: 38281712
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype.
Anorga S; Overstreet JM; Falke LL; Tang J; Goldschmeding RG; Higgins PJ; Samarakoon R
FASEB J; 2018 May; 32(5):2644-2657. PubMed ID: 29298862
[TBL] [Abstract][Full Text] [Related]
14. Early Growth Response 1 (Egr1) Is a Transcriptional Activator of NOX4 in Oxidative Stress of Diabetic Kidney Disease.
Hu F; Xue M; Li Y; Jia YJ; Zheng ZJ; Yang YL; Guan MP; Sun L; Xue YM
J Diabetes Res; 2018; 2018():3405695. PubMed ID: 29854821
[TBL] [Abstract][Full Text] [Related]
15. RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species.
Manickam N; Patel M; Griendling KK; Gorin Y; Barnes JL
Am J Physiol Renal Physiol; 2014 Jul; 307(2):F159-71. PubMed ID: 24872317
[TBL] [Abstract][Full Text] [Related]
16. NADPH oxidase 4 mediates TGF-β1/Smad signaling pathway induced acute kidney injury in hypoxia.
Cho S; Yu SL; Kang J; Jeong BY; Lee HY; Park CG; Yu YB; Jin DC; Hwang WM; Yun SR; Song HS; Park MH; Yoon SH
PLoS One; 2019; 14(7):e0219483. PubMed ID: 31318905
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.
Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P
Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962
[TBL] [Abstract][Full Text] [Related]
18. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
[TBL] [Abstract][Full Text] [Related]
19. Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis.
Zhang B; Chen X; Ru F; Gan Y; Li B; Xia W; Dai G; He Y; Chen Z
Cell Death Dis; 2021 Sep; 12(9):843. PubMed ID: 34511597
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor β1-induced collagen production in myofibroblasts is mediated by reactive oxygen species derived from NADPH oxidase 4.
Hotta Y; Uchiyama K; Takagi T; Kashiwagi S; Nakano T; Mukai R; Toyokawa Y; Yasuda T; Ueda T; Suyama Y; Murakami T; Tanaka M; Majima A; Doi T; Hirai Y; Mizushima K; Morita M; Higashimura Y; Inoue K; Fukui A; Okayama T; Katada K; Kamada K; Handa O; Ishikawa T; Naito Y; Itoh Y
Biochem Biophys Res Commun; 2018 Nov; 506(3):557-562. PubMed ID: 30361098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
